AEM vs ASIX

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

AdvanSix Inc. (ASIX) shows strong financial health with a Piotroski F-Score of 8/9, indicating solid operational fundamentals. However, the stock faces significant headwinds from deteriorating profitability, negative earnings and revenue growth, and poor analyst and insider sentiment. Despite trading below the Graham Number of $36.27 at $17.07, the market appears to be pricing in persistent operational challenges and weak future expectations. The combination of declining margins, negative operating cash flow trends, and insider selling raises concerns about sustainability and near-term recovery.